NCT06252220View on ClinicalTrials.gov

First in Human Study in Subjects With Obesity, But Otherwise Healthy

PHASE1RecruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Obesity
Interventions
DRUG

DA-1726

Active

DRUG

Placebo to DA-1726

Placebo

Trial Locations (1)

33014

RECRUITING

Clinical Pharmacology of Miami, LLC, Miami

Sponsors
All Listed Sponsors
lead

NeuroBo Pharmaceuticals Inc.

INDUSTRY